AMGN

Amgen Inc. News Headlines

$113.315
*  
5.985
 negative 
5.02%
Get AMGN Alerts
*Delayed - data as of Apr. 23, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMGN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

IBB, GILD, BIIB, AMGN: Large Inflows Detected at ETF
2/11/2014 12:18:35 PM - BNK Invest

Stock Market News for February 11, 2014 - Market News
2/11/2014 11:06:01 AM - Zacks.com

Cytokinetics Rises on Q4 Earnings Beat - Analyst Blog
2/10/2014 12:00:01 PM - Zacks.com

Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2014
2/10/2014 10:00:03 AM - NASDAQ.com News

The 20 Best Value Long Maturity Bond Trades On February 6, 2014
2/7/2014 1:57:00 PM - Seeking Alpha

Ex-Dividend Reminder: Entergy, TECO Energy and Amgen
2/7/2014 11:08:53 AM - BNK Invest

Emerging Market Misery And U.S. Large-Cap Euphoria
2/6/2014 12:23:00 PM - Seeking Alpha

Merck Misses on Earnings by a Penny - Analyst Blog
2/5/2014 1:12:01 PM - Zacks.com

Merck Misses Estimates in 4Q; Plans Increased Focus on Cancer
2/5/2014 10:05:00 AM - Fox Business

Merck Q4 Profit Down 14%, But Matches View; Sees 2014 Earnings In-line
2/5/2014 8:44:00 AM - RTT News

Lazard Ltd. Swings to Fourth-Quarter Profit
2/5/2014 8:02:00 AM - Dow Jones Business News

Merck in Pacts to Study Cancer Treatment
2/5/2014 7:55:00 AM - Dow Jones Business News

Merck 4Q Profit Falls 14%; Confirms Collaborations
2/5/2014 7:55:00 AM - Dow Jones Business News

Merck Profit Falls 14% on Sales Drop; Confirms Collaborations on Investigational Cancer Immunotherapy
2/5/2014 7:31:00 AM - Dow Jones Business News

Merck, Amgen,Incyte And Pfizer To Collaborate On Anti-Cancer Combination Studies
2/5/2014 7:01:00 AM - RTT News

Amgen, Merck Collaborate To Evaluate Combination Treatment For Advanced Melanoma
2/5/2014 6:34:00 AM - RTT News

Here's How Analysts Expect Merck To Report Wednesday
2/4/2014 1:52:00 PM - Seeking Alpha

Guidance Update From Actavis - Analyst Blog
2/3/2014 6:40:01 PM - Zacks.com

3 Reasons For Biotech Stock Advance To Continue
2/3/2014 6:35:00 PM - Investor's Business Daily

TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer
1/31/2014 5:18:00 PM - Seeking Alpha

Amgen - Focus On Growth And A Full Pipeline Can Continue To Drive Returns
1/31/2014 11:45:00 AM - Seeking Alpha

ARAY On The Rise, AERI Catching Eyes, CORT Growing Big, SLXP Gets FDA Date
1/30/2014 10:48:00 PM - RTT News

Amgen Says Evolocumab Meets Primary Goals In Late-Stage Study
1/30/2014 6:55:00 PM - RTT News

Amgen's Earnings Increase 30%, But Is It A Buy?
1/30/2014 8:37:00 AM - Seeking Alpha

Pharma Strength Expected To Continue With Eli Lilly
1/29/2014 8:53:00 PM - Seeking Alpha